• Portal do Governo Brasileiro
  • Atualize sua Barra de Governo
Faculdade de Farmácia
  • Institucional
  • Graduação
    • Biomedicina
    • Farmácia
      • O Curso
      • Ementas
      • Matriz Curricular
      • Projeto Pedagógico
  • Pós-Graduação
    • Análises Clínicas e Toxicológicas
    • Ciência de Alimentos
    • Ciências Farmacêuticas
    • Medicamentos e Assistência Farmacêutica
  • Editais
  • Serviços
    • ANÁLISE DE ÁGUA – Lab. Saúde Pública
    • CCATES
    • CEAF
    • Cedafar
    • CEMED
    • Gnosiah
    • LINBIO
    • Laboratório de Toxicologia
    • NDPA - Pesquisa Analítica
    • Nuclefar
  • Biblioteca
  • Alunos
    • Certificados
    • Portal de Alunos
    • Assessoria Educacional
    • Central de Oportunidades
    • Diretório Acadêmico de Farmácia
    • Centro Acadêmico de Biomedicina
    • Associação Atlética de Farmácia
    • Farmácia Jr
    • Mapa de Salas
  • Departamentos
    • Alimentos (ALM)
    • Análises Clínicas e Toxicológicas (ACT)
    • Farmácia Social (FAS)
    • Produtos Farmacêuticos (PFA)
  • Ações COVID-19
    • Lives FAFAR
    • Pensando Nisso
    • Inclusão Digital
    • LINBIO
  • PPGACT
    M.Sc. and Ph.D. in
    Clinical and Toxicological Analysis


    • About Us
    • Admissions
    • Research
    • Curriculum
    • Contact

Research

Laboratory diagnosis and therapy: hemostasis, inflammation, infection and neoplasia

Studies on hemostatic, cellular, biochemical, and molecular aspects through new laboratory methods and research of new biomarkers with potential application in the prevention, prognosis, diagnosis, and monitoring of treatment of diseases that can present with hypercoagulability, as well as inflammatory, infectious, and neoplastic diseases.

Investigations related to the diagnosis and therapy of inflammatory, infectious, neoplastic, and toxicological processes

Aims to foster in-depth studies on  cell signaling in inflammation; interactions between the plasminogen system and inflammation, and study of inflammation in experimental models of infectious diseases; use of radiolabeled long-circulating, pH-sensitive Liposomes for identifying prostate tumor and other diseases in an experimental model; development of recombinant vaccines against leishmaniosis comprising the identification and characterization of recombinant antigens capable of inducing protection against Leishmania infection; treatment and immunotherapy of Leishmaniosis; new alternatives for diagnosis of Visceral Leishmaniosis; epidemiology and molecular diagnostic of major pathogens in infectious diseases, STD agents such as HPV, Chlamydia, Neisseria gonorrhoeae, Mycoplasma and Ureaplasma, and waterborne protozoa such as Cryptosporidium, Giardia and Acanthamoeba.

Biomarkers in Clinical and Toxicological Analysis

Aims to conduct studies in order to identify new biomarkers for use in the clinical practice and correlate genetics and phenotype in patients with several diseases, as well as safety assessment studies of new drugs through preclinical toxicity tests (in vivo and in vitro).

 

Av. Presidente Antônio Carlos, 6627 - Campus Pampulha - CEP 31270-901
Belo Horizonte - MG - Brasil
  • Apresentação
  • Estrutura Organizacional
  • Corpo Docente
  • Corpo Administrativo
  • Laboratórios
    ▼
    • Toxicologia
    • Radioisótopos
    • Parasitologia Clínica
    • Microbiologia Clínica
    • Imunologia Clínica
    • Hematologia Clínica
    • Citologia Clínica
    • Bioquímica Clínica
  • Linhas de Pesquisa
  • Disciplinas
  • Editais
  • Serviços
  • Notícias
  • Contato